These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

753 related articles for article (PubMed ID: 19669399)

  • 21. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission.
    Naccarelli GV; Wolbrette DL; Samii S; Banchs JE; Penny-Peterson E; Gonzalez MD
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):24S-30S. PubMed ID: 21098416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
    Maund E; McKenna C; Sarowar M; Fox D; Stevenson M; Pepper C; Palmer S; Woolacott N
    Health Technol Assess; 2010 Oct; 14(Suppl. 2):55-62. PubMed ID: 21047492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dronedarone: Basic Pharmacology and Clinical Use.
    Tadros R; Nattel S; Andrade JG
    Card Electrophysiol Clin; 2016 Jun; 8(2):453-65. PubMed ID: 27261834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dronedarone for the management of atrial fibrillation.
    Brenner R; Delacrétaz E
    Swiss Med Wkly; 2011; 141():w13158. PubMed ID: 21370206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dronedarone: a novel antiarrhythmic agent for the treatment of atrial fibrillation.
    Duray GZ; Ehrlich JR; Hohnloser SH
    Curr Opin Cardiol; 2010 Jan; 25(1):53-8. PubMed ID: 19881340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
    Singh BN; Connolly SJ; Crijns HJ; Roy D; Kowey PR; Capucci A; Radzik D; Aliot EM; Hohnloser SH;
    N Engl J Med; 2007 Sep; 357(10):987-99. PubMed ID: 17804843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dronedarone. atrial fibrillation: too many questions about long-term adverse effects.
    Prescrire Int; 2010 Aug; 19(108):149-52. PubMed ID: 20939439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of dronedarone in the contemporary atrial fibrillation treatment].
    Dorantowicz R; Broncel M
    Pol Merkur Lekarski; 2011 Jan; 30(175):32-40. PubMed ID: 21542242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dronedarone for atrial fibrillation therapy.
    Marzocchi M; Lombardi F
    Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):675-83. PubMed ID: 21714598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter.
    Dale KM; White CM
    Ann Pharmacother; 2007 Apr; 41(4):599-605. PubMed ID: 17389667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The management of patients with atrial fibrillation and dronedarone's place in therapy.
    Cohen M; Boiangiu C
    Adv Ther; 2011 Dec; 28(12):1059-77. PubMed ID: 22170292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy.
    Wolbrette D; Gonzalez M; Samii S; Banchs J; Penny-Peterson E; Naccarelli G
    Vasc Health Risk Manag; 2010 Aug; 6():517-23. PubMed ID: 20730068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dronedarone in atrial fibrillation: the aftermath of the PALLAS trial.
    Salam AM
    Expert Rev Cardiovasc Ther; 2012 Nov; 10(11):1345-9. PubMed ID: 23244355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
    Krishnamoorthy S; Lip GY
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):473-81. PubMed ID: 19419255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologic management of atrial fibrillation: established and emerging options.
    Kalus JS
    J Manag Care Pharm; 2009 Aug; 15(6 Suppl B):S10-8. PubMed ID: 19678722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dronedarone.
    Patel C; Yan GX; Kowey PR
    Circulation; 2009 Aug; 120(7):636-44. PubMed ID: 19687370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of dronedarone in the treatment of atrial fibrillation/flutter in the aftermath of PALLAS.
    Naccarelli GV; Kowey PR
    Curr Cardiol Rev; 2014 Nov; 10(4):303-8. PubMed ID: 24821656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dronedarone for atrial fibrillation: a new therapeutic agent.
    Patel PD; Bhuriya R; Patel DD; Arora BL; Singh PP; Arora RR
    Vasc Health Risk Manag; 2009; 5():635-42. PubMed ID: 19688104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benefit-risk assessment of dronedarone in the treatment of atrial fibrillation.
    Adlan AM; Lip GY
    Drug Saf; 2013 Feb; 36(2):93-110. PubMed ID: 23329540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.